IHC of paraffin-embedded Carcinoma of thyroid tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded thyroid tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Adenocarcinoma of ovary tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Carcinoma of prostate tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Adenocarcinoma of endometrium tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded endometrium tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Carcinoma of bladder tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded colon tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Adenocarcinoma of breast tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Ovary tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded lung tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Kidney tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Adenocarcinoma of colon tissue using anti-XRCC4 mouse monoclonal antibody. (Dilution 1:50).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY XRCC4 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-XRCC4.